Why the study?
Does baseline autonomic nervous system function affect the blood pressure-lowering success of renal denervation in patients with treatment-resistant hypertension?
Does baseline autonomic nervous system function affect the blood pressure-lowering success of renal denervation in patients with treatment-resistant hypertension?
Patients with preexisting reduced sympathetic nervous system activity derive less blood pressure-lowering benefit from renal denervation.
OBJECTIVES: Renal denervation is an interventional approach aiming to reduce high blood pressure. Its efficacy is subject of controversial debate. We analyzed autonomic function in patients undergoing renal denervation to identify responders. METHODS: A total of 21 patients with treatment-resistant hypertension scheduled for renal denervation were included. Heart rate variability, pupillary function and sympathetic skin response were examined prior to intervention. Before and 1 or 3 months after intervention, 24-h ambulatory blood pressure readings were taken. RESULTS: Patients were stratified according to sympathetic nervous system function. Sympathetic activity was reduced in 12 participants (group 1) and normal or enhanced in nine patients (group 2). The mean of daytime systolic blood pressure decreased in groups 1 and 2 from 168 to 157 mmHg (95% confidence interval for difference, 1-21 mmHg, p = 0.035) and from 166 to 145 mmHg (8-34 mmHg, p = 0.005), respectively. In a linear model, blood pressure reduction was 11.3 mmHg (0.3-22 mmHg) greater in group 2 than in group 1 (p = 0.045). CONCLUSION: Patients with preexisting reduced activity of the sympathetic nervous system benefited less from renal denervation.
No takes yet. Share an insight, caveat, or question.
Fricke et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: